SCHEMBL6002933

SCHEMBL6002933

[CH2]CCOC(=O)N(OC)c1ccccc1OC

nearest known ligand 0.38

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
PTGIR P43119 1/20 0.37
ESR1 P03372 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
POLB P06746 1/20 0.36
CTSD P07339 1/20 0.36
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PAX8 Q06710 1/20 0.35
TLR9 Q9NR96 1/20 0.35
PABPC1 P11940 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7945830 0.71 ALDH1A1 (0.56) LMNASMN1; SMN2CTSDNPSR1TDP1
SCHEMBL5320162 0.70 HPGD (0.41) SMN1; SMN2POLBPAX8TLR9TDP1
SCHEMBL27656415 0.69 PAX8 (0.43) ESR1SMN1; SMN2POLBPAX8TLR9
SCHEMBL2095223 0.69 CHRNB2 (0.41) LMNASMN1; SMN2
SCHEMBL7824932 0.68 TSPO (0.44) LMNAESR1SMN1; SMN2POLBCTSD
SCHEMBL9625766 0.68 ALDH1A1 (0.41) LMNAPTGIRESR1SMN1; SMN2POLB
SCHEMBL10424602 0.66 CA1 (0.50) LMNAPTGIRSMN1; SMN2POLBCTSD
SCHEMBL514005 0.66 TSPO (0.45) ESR1SMN1; SMN2POLBNPSR1PAX8
SCHEMBL5012682 0.66 NPSR1 (0.50) LMNASMN1; SMN2NPSR1
SCHEMBL2214193 0.66 CA1 (0.48) LMNAESR1SMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed